AAAAAA
Results: 1-25/192
Authors:
SUMMERFELT WT
MELTZER HY
Citation: Wt. Summerfelt et Hy. Meltzer, EFFICACY VS. EFFECTIVENESS IN PSYCHIATRIC RESEARCH, Psychiatric services, 49(6), 1998, pp. 834-834
Authors:
HONG WW
RAK IW
CIURYLA VT
WILSON AM
KYLSTRA JW
MELTZER HY
CARPENTER WT
LEHMAN A
ARVANITIS LA
Citation: Ww. Hong et al., MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION, Schizophrenia research, 32(1), 1998, pp. 51-58
Authors:
PETRONIS A
VINCENT JB
PATERSON AD
BASSETT AS
HONER WG
GOTTESMAN II
TORREY EF
MELTZER HY
LIEBERMAN J
KENNEDY JL
Citation: A. Petronis et al., SEARCH FOR UNSTABLE DNA IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 135-135
Authors:
MCGURK SR
MELTZER HY
Citation: Sr. Mcgurk et Hy. Meltzer, THE EFFECTS OF ATYPICAL ANTIPSYCHOTIC-DRUGS ON COGNITIVE-FUNCTIONING IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 160-160
Authors:
MASELLIS M
BASILE V
MELTZER HY
LIEBERMAN JA
SEVY S
MACCIARDI FM
COLA P
HOWARD A
BADRI F
NOTHEN MM
KALOW W
KENNEDY JL
Citation: M. Masellis et al., SEROTONIN SUBTYPE-2 RECEPTOR GENES AND CLINICAL-RESPONSE TO CLOZAPINEIN SCHIZOPHRENIA-PATIENTS, Neuropsychopharmacology, 19(2), 1998, pp. 123-132
Authors:
YOUNG CD
MELTZER HY
DEUTCH AY
Citation: Cd. Young et al., EFFECTS OF DESMETHYLCLOZAPINE ON FOS PROTEIN EXPRESSION IN THE FOREBRAIN - IN-VIVO BIOLOGICAL-ACTIVITY OF THE CLOZAPINE METABOLITE, Neuropsychopharmacology, 19(1), 1998, pp. 99-103
Authors:
MELTZER HY
PRINGUEY D
Citation: Hy. Meltzer et D. Pringuey, TREATMENT-RESISTANT SCHIZOPHRENIA - THE IMPORTANCE OF EARLY DETECTIONAND TREATMENT - PROCEEDINGS OF A SYMPOSIUM HELD AT THE 6TH WORLD CONGRESS OF BIOLOGICAL PSYCHIATRY, NICE, FRANCE, JUNE 22, 1997 - INTRODUCTION, Journal of clinical psychopharmacology, 18(2), 1998, pp. 1-1
Authors:
MELTZER HY
LEE M
COLA P
Citation: Hy. Meltzer et al., THE EVOLUTION OF TREATMENT RESISTANCE - BIOLOGIC IMPLICATIONS, Journal of clinical psychopharmacology, 18(2), 1998, pp. 5-11
Authors:
MELTZER HY
Citation: Hy. Meltzer, SUICIDE IN SCHIZOPHRENIA - RISK-FACTORS AND CLOZAPINE TREATMENT, The Journal of clinical psychiatry, 59, 1998, pp. 15-20
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., MEASURING OUTCOME IN SCHIZOPHRENIA - DIFFERENCES AMONG THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 3-9
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., CLINICAL DEVELOPMENT OF ATYPICAL ANTIPSYCHOTICS - RESEARCH DESIGN ANDEVALUATION, The Journal of clinical psychiatry, 59, 1998, pp. 10-16
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ADVERSE-EFFECTS OF THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 17-22
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA S
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSMENT OF EPS AND TARDIVE-DYSKINESIA IN CLINICAL-TRIALS, The Journal of clinical psychiatry, 59, 1998, pp. 23-27
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSING THE EFFECTS OF ATYPICAL ANTIPSYCHOTICS ON NEGATIVE SYMPTOMS, The Journal of clinical psychiatry, 59, 1998, pp. 28-34
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., EVALUATING THE EFFECTS OF ANTIPSYCHOTICS ON COGNITION IN SCHIZOPHRENIA, The Journal of clinical psychiatry, 59, 1998, pp. 35-40
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS, The Journal of clinical psychiatry, 59, 1998, pp. 41-45
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., TREATMENT OF SPECIAL POPULATIONS WITH THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 46-52
Authors:
JOPE RS
SONG L
GRIMES CA
PACHECO MA
DILLEY GE
LI XH
MELTZER HY
OVERHOLSER JC
STOCKMEIER CA
Citation: Rs. Jope et al., SELECTIVE INCREASES IN PHOSPHOINOSITIDE SIGNALING ACTIVITY AND G-PROTEIN LEVELS IN POSTMORTEM BRAIN FROM SUBJECTS WITH SCHIZOPHRENIA OR ALCOHOL DEPENDENCE, Journal of neurochemistry, 70(2), 1998, pp. 763-771
Authors:
ICHIKAWA J
KUROKI T
DAI J
MELTZER HY
Citation: J. Ichikawa et al., EFFECT OF ANTIPSYCHOTIC-DRUGS ON EXTRACELLULAR SEROTONIN LEVELS IN RAT MEDIAL PREFRONTAL CORTEX AND NUCLEUS-ACCUMBENS, European journal of pharmacology, 351(2), 1998, pp. 163-171
Authors:
ICHIKAWA J
KUROKI T
MELTZER HY
Citation: J. Ichikawa et al., DIFFERENTIAL-EFFECTS OF CHRONIC IMIPRAMINE AND FLUOXETINE ON BASAL AND AMPHETAMINE-INDUCED EXTRACELLULAR DOPAMINE LEVELS IN RAT NUCLEUS-ACCUMBENS, European journal of pharmacology, 350(2-3), 1998, pp. 159-164
Authors:
FATEMI SH
SIDWELL R
KIST D
AKHTER P
MELTZER HY
BAILEY K
THURAS P
SEDGWICK J
Citation: Sh. Fatemi et al., DIFFERENTIAL EXPRESSION OF SYNAPTOSOME-ASSOCIATED PROTEIN-25 KDA [SNAP-25] IN HIPPOCAMPI OF NEONATAL MICE FOLLOWING EXPOSURE TO HUMAN INFLUENZA-VIRUS IN-UTERO, Brain research, 800(1), 1998, pp. 1-9
Authors:
WILLINS DL
MELTZER HY
Citation: Dl. Willins et Hy. Meltzer, SEROTONIN 5-HT2C AGONISTS SELECTIVELY INHIBIT MORPHINE-INDUCED DOPAMINE EFFLUX IN THE NUCLEUS-ACCUMBENS, Brain research, 781(1-2), 1998, pp. 291-299
Authors:
RAJKOWSKA G
WEI J
PITTMAN SD
PAGE W
RICHMOND M
DILLEY G
MELTZER HY
OVERHOLSER JC
STOCKMEIER CA
Citation: G. Rajkowska et al., HISTOPATHOLOGY OF THE ORBITOFRONTAL CORTEX IN MAJOR DEPRESSION, Biological psychiatry, 43, 1998, pp. 307-307
Authors:
LEE M
MELTZER HY
Citation: M. Lee et Hy. Meltzer, EFFECT OF APOMORPHINE ON PLASMA-CORTISOL IN SCHIZOPHRENIA, Biological psychiatry, 43, 1998, pp. 444-444
Authors:
MELTZER HY
Citation: Hy. Meltzer, ZIPRASIDONE - VIEWPOINT, CNS DRUGS, 8(2), 1997, pp. 160-161